For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
FUR021
Furo[2,3-d]-1,3-dioxol-5-ol, tetrahydro-2,2-dimethyl-6-(phenylmethoxy)-, (3aR,5S,6R,6aR)-
1026679-81-1
GLU001
¦Â-D-Glucopyranose, 2,3,4,6-tetraacetate 1-(2,2,2-trichloroethanimidate)
[92052-29-4]
GLU002
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-
1028977-37-8
GLU004
-D-Glucopyranoside, methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-
[1030825-21-8]
GLU006
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-
[461432-26-8]
GLU008
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
[842133-18-0]
GLU013
L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-
[137281-23-3]
Disodium [150399-23-8]
GLU014
(3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-(5-(4-fluorophenyl)thiophene-2-carbonyl)-4-methylphenyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate
[1312810-97-1]
GLU015
¦Á-D-Glucofuranose, 1,2:5,6-bis-O-(1-methylethylidene)-
[582-52-5]
GLU016
¦Â-D-Glucopyranose, 1,2,3,4,6-pentakis(2,2-dimethylpropanoate)
[81058-26-6]
GLU017
¦Á-D-Glucopyranose, 1,2,3,4,6-pentakis(2,2-dimethylpropanoate)
[1213234-53-7]
GLU018
¦Á-D-Glucopyranosyl bromide, 2,3,4,6-tetrakis(2,2-dimethylpropanoate)
[81058-27-7]
GLY001
¦Â-D-glycero-D-galacto-non-2-enonic acid, 5-(acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-,methyl ester, 7,8,9-triacetate
[130525-58-5]
GLY003
Glycine, N-(1-oxobutyl)-, ethyl ester
[90205-46-2]
GLY004
Glycine, N-(2-cyanoethyl)-, ethyl ester
[44981-94-4]
GLY005
Glycine, N-phenyl-N-(phenylmethyl)-
[23582-63-0]
GLY006
Glycine, N-phenyl-N-(phenylmethyl)-, ethylester
[49790-83-2]
GLY008
Glycine, N-methyl-N-(phosphonomethyl)-
[24569-83-3]
GLY009
Glycine, N-(phosphonomethyl)-
[1071-83-6]
GLY014
D-glycero-D-galacto-Non-2-enonic acid,5-(acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-, methyl ester, 7-acetate
[1070897-55-0]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help